Park Y - Search Results

1

Groupwise envelope models for imaging genetic analysis.

Park Y, Su Z, Zhu H. Park Y, et al. Biometrics. 2017 Dec;73(4):1243-1253. doi: 10.1111/biom.12689. Epub 2017 Mar 21. Biometrics. 2017. PMID: 28323341 Free PMC article.

2

Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.

Park Y, Lin R. Park Y, et al. Biometrics. 2020 Jun;76(2):595-598. doi: 10.1111/biom.13246. Epub 2020 Apr 6. Biometrics. 2020. PMID: 32251522 No abstract available.

3

Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers.

Park Y, Liu S, Thall PF, Yuan Y. Park Y, et al. Biometrics. 2022 Mar;78(1):60-71. doi: 10.1111/biom.13421. Epub 2021 Jan 27. Biometrics. 2022. PMID: 33438761 Free PMC article.

4

Envelope-based partial partial least squares with application to cytokine-based biomarker analysis for COVID-19.

Park Y, Su Z, Chung D. Park Y, et al. Stat Med. 2022 Oct 15;41(23):4578-4592. doi: 10.1002/sim.9526. Epub 2022 Jul 15. Stat Med. 2022. PMID: 36111618 Free PMC article.

5

Bayesian inference for multivariate probit model with latent envelope.

Lee K, Park Y. Lee K, et al. Among authors: park y. Biometrics. 2024 Jul 1;80(3):ujae059. doi: 10.1093/biomtc/ujae059. Biometrics. 2024. PMID: 38949889

6

Hybrid design evaluating new biomarkers when there is an existing screening test.

Park Y, Yuan Y, Ning J, Liu S, Feng Z. Park Y, et al. Stat Med. 2021 Apr 15;40(8):2037-2054. doi: 10.1002/sim.8890. Epub 2021 Feb 4. Stat Med. 2021. PMID: 33540472 Free PMC article.

7

On the coherence of model-based dose-finding designs for drug combination trials.

Park Y, Liu S. Park Y, et al. PLoS One. 2020 Nov 30;15(11):e0242561. doi: 10.1371/journal.pone.0242561. eCollection 2020. PLoS One. 2020. PMID: 33253260 Free PMC article.

8

A randomized group sequential enrichment design for immunotherapy and targeted therapy.

Park Y, Liu S. Park Y, et al. Contemp Clin Trials. 2022 May;116:106742. doi: 10.1016/j.cct.2022.106742. Epub 2022 Apr 8. Contemp Clin Trials. 2022. PMID: 35405335

9

Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy.

Miller D, Livingston JA, Park Y, Posey K, Godbole S, Skubitz K, Robinson SI, Agulnik M, Davis LE, Van Tine BA, Hirbe AC, Parkes A. Miller D, et al. Among authors: park y. Cancer Med. 2022 Sep;11(18):3471-3478. doi: 10.1002/cam4.4707. Epub 2022 Mar 28. Cancer Med. 2022. PMID: 35343652 Free PMC article.

10

Data-driven monitoring for phase II clinical trial designs based on percentile event time test.

Park Y, Xu Z. Park Y, et al. J Biopharm Stat. 2025 Jan 2;35(1):125-144. doi: 10.1080/10543406.2023.2292209. Epub 2023 Dec 22. J Biopharm Stat. 2025. PMID: 38131110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,043 results

Search Page

Filters